Turkish Journal of Pathology · 2020 · 17 citations · 19 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor PathologyBreast PathologyCancer Molecular PathologyMalignant NeoplasmsMalignant TumorsMolecular Classification Of TumorsTumor ClassificationMorphologic VariantsMutationPapillary Thyroid Carcinoma PathologyThyroid Cancer Pathology
Breast carcinomas are a heterogeneous group of malignancy, having variable clinical outcomes depending on their cellular and molecular properties. Tall cell carcinoma with reverse polarity (TCCRP) is a recently described rare entity, which shares morphological features with tall cell variant of papillary thyroid carcinoma but has a distinct morphological, immunohistochemical, and molecular profile. We describe a case of a 40-year-old female patient, who presented with lump in the breast. The patient underwent lumpectomy and was diagnosed as tall cell carcinoma with reverse polarity. Immunohistochemistry and bi-directional Sanger sequencing for IDH2 mutation were used for diagnosis. Tall cell carcinoma with reverse polarity is a rare and newly described entity with characteristic morphological and molecular findings, which carries an excellent prognosis.
19
Maria Fernanda Amary, Krisztián Bácsi, Francesca Maggiani et al. · The Journal of Pathology · 2011 · 994 citations · Full text
The American journal of surgical pathology
Lippincott Williams Wilkins · 1977 · 513 citations
The prognostic significance of IDH2 mutations in AML depends on the location of the mutation
Claire L. Green, C. M. Evans, Lu Zhao et al. · Blood · 2011 · 267 citations · Full text
<i>IDH2</i> Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity
Sarah Chiang, Britta Weigelt, Huei‐Chi Wen et al. · Cancer Research · 2016 · 134 citations · Full text